Jacobson Pharma Corporation Limited

2633

KYG677291067

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:28 2024-05-20 am EDT			5-day change	1st Jan Change
0.61 ^HKD	-1.61%		+1.67%	-4.69%

Feb. 27	Jacobson Pharma Raises HK$39 Million from Share Placement	MT
2023	Jacobson Pharma Reports 42% Fiscal H1 Profit Growth; Shares Rise	MT

Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2021

November 26, 2021 at 05:58 am EST

Jacobson Pharma Corporation Limited reported earnings results for the half year ended September 30, 2021. For the half year, the company reported sales was HKD 750.41 million compared to HKD 695.43 million a year ago. Net income was HKD 80.04 million compared to HKD 102.51 million a year ago. Basic earnings per share from continuing operations was HKD 0.0418 compared to HKD 0.0535 a year ago. Basic earnings per share was HKD 0.0418 compared to HKD 0.0535 a year ago.

Latest news about Jacobson Pharma Corporation Limited

Jacobson Pharma Raises HK$39 Million from Share Placement	Feb. 27	MT
Jacobson Pharma Reports 42% Fiscal H1 Profit Growth; Shares Rise	Nov. 24	MT
Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 23	CI
Jacobson Pharma Corporation Limited Announces Interim Dividend for the Six Months Ended September 30, 2023, Payable on 10 January 2024	Nov. 23	CI
JBM (Healthcare), Jacobson Pharma Shares Rise on M&A Deal	23-10-04	MT
Jacobson Pharma Corporation Declares A Final Dividend for the Year Ended 31 March 2023	23-08-01	CI
Jacobson Pharma's Dividend Shrinks Despite Surge in FY23 Net Profit	23-06-15	MT
Jacobson Pharma Corporation Limited Proposes Final Dividend for the Year Ended 31 March 2023, Payable on 1 September 2023	23-06-15	CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-15	CI
Jacobson Pharma Forecasts 40% Growth in FY23 Profit	23-05-31	MT
Jacobson Pharma Corporation Limited Provides Earning Guidance for the Year Ended 31 March 2023	23-05-31	CI
Jacobson Pharma Boosts Interim Dividend as April-September Profit Increases	22-11-28	MT
Jacobson Pharma Corporation Limited Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 29 December 2022	22-11-25	CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-25	CI
Jacobson Pharma Expects Up to 70% Rise in April-September Profit; Shares Rise 4%	22-11-02	MT
Jacobson Pharma Corporation Limited Provides Earnings Guidance for the Six Months Ended 30 September 2022	22-11-02	CI
Jacobson Pharma Corporation Limited Further Amends Its Facility Agreement	22-10-26	CI
Jacobson Pharma Unit Raises Loan to $10 Million Over Rising Interest Rates	22-10-26	MT
Jacobson Pharma Corporation Limited Approves Final Dividend for the Year Ended 31 March 2022	22-09-23	CI
Jacobson Pharma Unit to Extend Shareholder's Loan	22-07-18	MT
Jacobson Pharma CEO Increases Stake; Shares Rise 3%	22-07-11	MT
Jacobson Pharma Posts Higher FY22 Profit	22-06-29	MT
Jacobson Pharma Corporation Limited Proposes Final Dividend for the Year Ended 31 March 2022, Payable on 18 October 2022	22-06-29	CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-29	CI
Jacobson Pharma Corporation Limited Announces Appointment of Members of Environmental, Social and Governance Committee	22-06-29	CI

Chart Jacobson Pharma Corporation Limited

Duration

Period

Chart Jacobson Pharma Corporation Limited

More charts

Company Profile

Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.

Sector

Pharmaceuticals

Calendar

2024-06-24 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
JACOBSON PHARMA CORPORATION LIMITED	-4.69%	159M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.63%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.99%	22.71B
SANDOZ GROUP AG	+18.22%	15.15B
CIPLA LIMITED	+12.66%	13.61B
ZYDUS LIFESCIENCES LIMITED	+60.18%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.35%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.65%	5.63B

Generic Pharmaceuticals